ASX - By Stock
|
IXR |
Re:
Ann: Ionic Technologies Starts Continuous Magnet REO Production
|
|
Uboy
|
24 |
10K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
24
|
10K
|
0
|
|
ASX - By Stock
|
DUB |
Re:
Dubber.Dubber.Do.
|
|
Uboy
|
8.1K |
3.7M |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
8.1K
|
3.7M
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
257 |
75K |
10 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
257
|
75K
|
10
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
257 |
75K |
15 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
257
|
75K
|
15
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
257 |
75K |
22 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
257
|
75K
|
22
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
257 |
75K |
21 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
257
|
75K
|
21
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Uboy
|
621 |
143K |
16 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
621
|
143K
|
16
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
257 |
75K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
257
|
75K
|
19
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
Uboy
|
4 |
1.5K |
8 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
4
|
1.5K
|
8
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
39K |
1 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
39K
|
1
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
39K |
7 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
7
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
39K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
1
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
39K |
11 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
39K
|
11
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
39K |
12 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
39K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
Uboy
|
81 |
20K |
17 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
81
|
20K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to participate in upcoming investor conferences
|
|
Uboy
|
15 |
4.3K |
10 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
15
|
4.3K
|
10
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
7 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
25 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
25
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
11 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
11
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Director Retirement
|
|
Uboy
|
33 |
10K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
33
|
10K
|
3
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Director Retirement
|
|
Uboy
|
33 |
10K |
2 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
NXL |
Re:
NUIX vs ASIC
|
|
Uboy
|
17 |
5.9K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
17
|
5.9K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
20 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
20
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
49K |
14 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
190
|
49K
|
14
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
49K |
17 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
190
|
49K
|
17
|
|
ASX - By Stock
|
FFX |
Re:
General discussion
|
|
Uboy
|
9.9K |
3.2M |
25 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
9.9K
|
3.2M
|
25
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
49K |
6 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
190
|
49K
|
6
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
49K |
9 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
49K
|
9
|
|
ASX - By Stock
|
WHC |
Re:
Climate Change
|
|
Uboy
|
820 |
152K |
2 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
820
|
152K
|
2
|
|
ASX - By Stock
|
WHC |
Re:
Climate Change
|
|
Uboy
|
820 |
152K |
11 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
820
|
152K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Other indications
|
|
Uboy
|
64 |
16K |
24 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
64
|
16K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive new DMD Combination Therapy Data in mdx mice
|
|
Uboy
|
66 |
18K |
22 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
66
|
18K
|
22
|
|
ASX - By Stock
|
NXL |
Re:
Ann: FY23 Preliminary Results Update
|
|
Uboy
|
70 |
23K |
0 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
Uboy
|
75 |
21K |
14 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
75
|
21K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Institutional Placement and proposed Share Purchase Plan SPP
|
|
Uboy
|
71 |
18K |
3 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
71
|
18K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Uboy
|
158 |
44K |
6 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Uboy
|
1.0K |
300K |
26 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
1.0K
|
300K
|
26
|
|
ASX - By Stock
|
NXL |
Re:
Growing Nuix ACV
|
|
Uboy
|
22 |
11K |
1 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
22
|
11K
|
1
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Nuix Acquires Automation Partner Rampiva
|
|
Uboy
|
18 |
7.1K |
1 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
18
|
7.1K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
13 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
13
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Uboy
|
99 |
28K |
19 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
99
|
28K
|
19
|
|
ASX - By Stock
|
NXL |
Re:
Ann: ASIC Investigation
|
|
Uboy
|
12 |
6.5K |
2 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
12
|
6.5K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Uboy
|
99 |
28K |
7 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
99
|
28K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Uboy
|
99 |
28K |
14 |
13/05/23 |
13/05/23 |
ASX - By Stock
|
99
|
28K
|
14
|
|
ASX - By Stock
|
PER |
Sarepta FDA Hearing
|
|
Uboy
|
99 |
28K |
21 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
99
|
28K
|
21
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
5 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Conference Presentation
|
|
Uboy
|
5 |
2.3K |
5 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
5
|
2.3K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
8 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Uboy
|
1.0K |
300K |
17 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
1.0K
|
300K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing
|
|
Uboy
|
31 |
9.8K |
6 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
31
|
9.8K
|
6
|
|